Immunotherapy extends survival in mouse model of hard-to-treat breast cancer (video)
A new immunotherapy approach using nanoparticles has shown promising results in extending the survival of mice with triple negative breast cancer. The treatment, which incorporates oxidized tumor cell lysates, triggered a stronger immune response and led to complete remission in two-thirds of treated mice.